Bio-Rad Launches New PTC Tempo Thermal Cyclers
Bio-Rad Laboratories announced the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications.
Bio-Rad Laboratories announced the launch of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, designed to support PCR applications.
Roche received 510(k) clearance from the FDA for the cobas pure integrated solutions, new to the cobas family of Serum Work Area solutions.
Thermo Fisher Scientific has announced the launch of its fully-automated analyzers specifically designed for enzyme assay applications.
The Bill and Melinda Gates Foundation has granted the partners $885,000 to develop an advanced rapid diagnostic for onchocerciasis.
Read MoreIn support of its pharmaceutical and clinical research clients, ABL has adopted the Cira platform for multiplex and ultrasensitive biomarker analysis.
Read MoreSiemens Healthineers has announced receipt of the CE mark and global commercial availability of its Atellica solution, consisting of flexible, scalable, automation-ready immunoassay and chemistry analyzers.
Read MoreThe Atellica Solution combines clinical chemistry and immunoassay analyzers with sample management components to form a scalable system suited for both mid- and high-volume diagnostic laboratories.
Read MoreThis month’s issue features immunoassay analyzers from such companies as Bio-Rad Laboratories, Dynex Technologies, Ortho Clinical Diagnostics, and Sekisui Diagnostics.
Read MoreThis month’s issue features immunoassay analyzers from such companies as Arlington Scientific and Dynex Technologies.
Read MoreThis month’s Product Spotlight features chemistry and integrated analyzers from such companies as MedTest, Sekisui Diagnostics, and Siemens Healthineers.
Read MoreThe diagnostic system features objective results interpretation and connectivity capabilities, and can be used to evaluate lateral-flow immunoassays in a wide variety of formats.
Read MoreFDA has reclassified antigen-based rapid influenza virus antigen detection systems intended to detect influenza virus directly from clinical specimens from Class I devices into Class II devices subject to special controls.
Read MoreThe company’s open, flexible, and scalable system is designed to empower clinical laboratorians to take complete control of their facilities.
Read MoreThe company has launched its next-generation wireless rapid diagnostic system for detection of group A Strep, influenza A and B, and respiratory syncytial virus.
Read MoreThe company’s Atellica Solution is expected to offer game-changing speed and flexibility for clinical chemistry and immunoassay testing.
Read MoreCurrently in development and not yet approved for sale, the system seeks to overcome existing sensitivity barriers in immunochemistry diagnostics.
Read MoreThe Cobas e 801 module is a dedicated, high-volume immunoassay system now available for countries accepting the CE mark.
Read MoreUltrasensitive assays enable researchers to detect proteins that are expressed at very low levels in response to drug treatment.
Read More